trending Market Intelligence /marketintelligence/en/news-insights/trending/oGcPj41FsbI-LFQVTsCw2A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Beiersdorf to use Insilico Medicine's AI tech for skin research

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Beiersdorf to use Insilico Medicine's AI tech for skin research

German maker of personal-care products Beiersdorf Aktiengesellschaft said Jan. 8 that it has partnered with Insilico Medicine Inc. to work on discovering new and safe bioactive ingredients for a specific skin indication.

The company said it will use Insilico Medicine's next-generation artificial intelligence to generate and analyze new molecules for specific skin indications.

Beiersdorf, which makes Nivea brand products said the bioactive ingredients will serve as the basis for developing skin care products.

"We are delighted to now be working with Insilico Medicine as a veritable expert when it comes to artificial intelligence. We are able to evaluate new active ingredients significantly more quickly and more efficiently by simulating biological effects in silico. This enables us to cater even better to the consumers' as yet unmet skin care needs," May Shana'a, Beiersdorf's senior corporate vice president for research and development, said in a statement.